Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.
Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at news conference.
More than 150 vaccines are being developed and tested around the world to stop the COVID-19 pandemic, with 25 in human clinical trials, according to the World Health Organization. Several other emerging markets in Asia and the Middle East have followed a similar strategy, consultancy Oxford Business Group highlighted in a report on Tuesday.
Walvax’s experimental vaccine is currently under early testing at a Chinese military research institute.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mexico City's mayor self-isolates after colleague tests positive for Covid-19The coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
China's Sinopharm starts Phase III trial of COVID-19 vaccine in BahrainChinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar trials in the United Arab Emirates last month, Bahrain's health ministry said on Monday.
Read more »
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaChina's Sinovac Biotech Ltd launched on Tuesday a late-stage human trial involving as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Read more »
Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 detailsChina's Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Read more »
Doctors, Community Groups Struggle to Tackle Covid-19 Racial DisparitiesLanguage barriers, distrust and other obstacles are complicating efforts to get Covid-19 testing and treatment to Black people, Latinos and Native Americans in hard-hit communities
Read more »